| NDC Code | 25021-671-20 |
|---|
| Package Description | 5 VIAL in 1 CARTON (25021-671-20) > 20 mL in 1 VIAL |
|---|
| Product NDC | 25021-671 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Ropivacaine Hydrochloride |
|---|
| Non-Proprietary Name | Ropivacaine Hydrochloride |
|---|
| Dosage Form | INJECTION, SOLUTION |
|---|
| Usage | EPIDURAL; INFILTRATION; PERINEURAL |
|---|
| Start Marketing Date | 20140923 |
|---|
| End Marketing Date | 20190331 |
|---|
| Marketing Category Name | ANDA |
|---|
| Application Number | ANDA090318 |
|---|
| Manufacturer | Sagent Pharmaceuticals |
|---|
| Substance Name | ROPIVACAINE HYDROCHLORIDE |
|---|
| Strength | 2 |
|---|
| Strength Unit | mg/mL |
|---|
| Pharmacy Classes | Amide Local Anesthetic [EPC],Amides [CS],Local Anesthesia [PE] |
|---|